Last summer, Brain Canada and JDRF officially launched the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a unique program that supports research on interventions that address mental health concerns in people with type 1 diabetes (T1D). Living with a chronic illness like diabetes is hard. As a result […]
Christine MacGibbon: University Student, Former Dancer & Model Diagnosed: 9 years old Christine’s journey as a T1D warrior began 24 years ago. This was a pivotal moment for her and her family, as it had an immense emotional and physical toll. In her personal and professional life, Christine has naturally evolved into an advocate, learning […]
Health Canada has approved clinical trials that could lead the way for cell replacement therapy that does not require immune suppression in people with type 1 diabetes. JDRF is the leading charitable funder of research into type 1 diabetes in Canada, with a focus on research that will help improve lives today, and lead to […]
The pace of type 1 diabetes (T1D) research is moving faster than ever before. In November 2021 to mark November’s National Diabetes Awareness Month, JDRF announced a new investment of $7 million to support four Canadian research teams as part of the JDRF-CIHR Partnership to Defeat Diabetes, which will help to accelerate development of stem cell-based therapies for T1D as well as improve pediatric diabetes […]
Since the #AccessforAll campaign launched in 2019, we have seen considerable success with five provinces and one territory introducing new coverage for Continuous Glucose Monitors (CGM) and Flash Glucose Monitors (Flash GM). As a result, thousands of Canadians living with type 1 diabetes (T1D) have been able to access this diabetes technology, reducing individual out-of-pocket […]
January 23, 2022 is the 100th anniversary of the first successful insulin injection for diabetes in a human. Prior to this, a diagnosis of type 1 diabetes (T1D) meant certain death. On this date, a fourteen-year-old boy named Leonard Thomspon, who was dying from complications of T1D received the first real treatment for the disease. […]
Bell annually runs its #BellLetsTalk campaign, raising awareness and helping to combat the stigma surrounding mental illness in Canada. Living with type 1 diabetes (T1D), whether it’s you, your child, a friend or loved one, has an impact that extends far beyond physical health. The stress of managing a chronic condition, both from the time […]
Principal researcher confirms trial participants with a history of hypoglycemia unawareness are now insulin independent. Funding cell replacement therapies research is one of JDRF’s most critical undertakings globally, in its efforts to support the most promising cure-based research into type 1 diabetes (T1D). On January 10, 2022, Sernova Corp. provided a progress update on […]
January 23rd marks the 100th Anniversary of the first successful insulin injection JDRF’s primary goal is to cure type 1 diabetes (T1D) through research – as quickly as possible. To support people with T1D while cure research is advancing, we also fund ground-breaking research that seeks to make life with T1D easier, safer and healthier. […]
JDRF is committed to providing timely information about the latest research updates relevant to the diabetes community. Early January 2022 researchers from the Centers for Disease Control and Prevention (CDC) in the United States reported that children who have recovered from COVID-19 may be at an increased risk of being diagnosed with diabetes. The CDC’s […]
What is the Coxsackie B virus and how does it relate to diabetes? JDRF is committed to funding the most promising research into cures for diabetes, and better understanding the mechanisms of the disease. One of the most significant challenges of preventing or curing type 1 diabetes (T1D) is that we don’t yet know its […]
A recent study held in Australia sought to answer the question: for children and adolescents with type 1 diabetes (T1D), does a hybrid closed-loop (HCL) system improve glycemic and psychosocial outcomes compared with conventional management? The study set out to compare the glycemic control or Time in Range (TIR) and the psychosocial outcomes of a […]
